International Minerals and Chemical Corporation Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: New York NY United States (1986)
Status: No NME R&D (1986)

Organization Overview

First Clinical Trial
None
First Marketed Drug
1987
acetaminophen (tylenol)
First NDA Approval
2022
terlipressin (Terlivaz)
Last Known Activity
1987

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

International Agricultural Corporation | International Minerals and Chemical Corporation (IMCERA Group Inc)

Active Ingredients

Marketed Drugs (16)

Key: International Minerals and Chemical Corporation (7) Acquired (9)

acetaminophen (tylenol) (2010)

butalbital (fiornal) (1990)

fibrinogen (human) (RiaSTAP) (2015)

gadoversetamide (optimark) (1999)

hydrocodone (hycodan) (1987)

iothalamate sodium i-125 (GloFil) (1996)

ioversol (optiray) (1998)

methoxsalen (1999)

nitric oxide (inomax) (1999)

oxycodone (oxycontin) (2014)

pemoline (cylert) (2001)

propoxyphene (Darvon) (2001)

sodium chloride (2006)

terlipressin (Terlivaz) (2022 NDA)

theophylline (synophylate) (1997)

thrombin (bovine) (Thrombostat) (2015)

Drugs in Phase 4 Trials (17)

Key: International Minerals and Chemical Corporation (0) Acquired (17)

acetaminophen (tylenol) (35 trials)

corticotropin (acthar) (57 trials)

gadoversetamide (optimark) (1 trial)

hydromorphone (diladid) (7 trials)

in111-octreoscan (2 trials)

iodixanol (visipaque) (1 trial)

ioversol (optiray) (1 trial)

methoxsalen (12 trials)

methylprednisolone (medrol) (5 trials)

morphine (3 trials)

nitric oxide (inomax) (40 trials)

nitrogen (11 trials)

nitrous oxide (1 trial)

oxycodone (oxycontin) (11 trials)

prednisone (meticorten) (3 trials)

sodium chloride (5 trials)

tacrolimus (prograf) (4 trials)

Drugs in Phase 3 Trials (13)

Key: International Minerals and Chemical Corporation (0) Acquired (13)

baclofen (lioresal) (1 trial)

calfactant (infasurf) (1 trial)

chlorhexidine (hibitane) (1 trial)

cyclosporine (sandimmune) (2 trials)

endotoxin (2 trials)

gelatin (3 trials)

human fibrin (Tisseel) (4 trials)

hydrocodone (hycodan) (8 trials)

omiganan (2 trials)

ornithine (2 trials)

oxygen (4 trials)

povidone-iodine (betadine) (1 trial)

terlipressin (Terlivaz) (3 trials)

Drugs in Phase 2 Trials (7)

Key: International Minerals and Chemical Corporation (0) Acquired (7)

carbon monoxide (1 trial)

diclofenac (voltaren) (3 trials)

etanercept (enbrel) (1 trial)

mycophenolate (CellCept) (1 trial)

rifaximin (xifaxan) (1 trial)

sodium sulfide (3 trials)

stem cells (1 trial)

Drugs in Phase 1 Trials (6)

Key: International Minerals and Chemical Corporation (0) Acquired (6)

chlorpheniramine (ChlorTrimeton) (2 trials)

dexchlorpheniramine maleate (polaramine) (2 trials)

doxorubicin (Doxil) (1 trial)

expressgraft-c9t1 skin tissue (1 trial)

fentanyl (Innovar) (1 trial)

mnk-010 (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 190
  • # of Trial APIs: 43